Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$6.63 USD
-0.06 (-0.90%)
Updated May 14, 2024 04:00 PM ET
After-Market: $6.64 +0.01 (0.15%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
Ironwood Pharmaceuticals, Inc. [IRWD]
Reports for Purchase
Showing records 981 - 1000 ( 1015 total )
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Q4:12 EPS, All Eyes on Linzess Launch, We Believe Risks Outweigh Rewards, Reiterate UNDERPERFORM; PT to $11
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
$175M Debt Deal Solves Near-Term Cash Crunch at a Cost, We Still Project Significant Cash Needs, Reiterate UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Top-line Plecanatide Data Shows Lower Clinical Benefit Rate vs. Linaclotide and Misses Some Secondary Endpoints - Reiterate UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
AZ China Deal Nets $25 Million - NEXIUM Co-promote Doesn''t Off-Set LINZESS Detail Costs - Cash Needs Remain - REITERATE UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Q3:12 Financial Update -- 3 Quarters of Cash - Reiterate UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of October 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Pricing Announcement Next, Launch Risks Ahead -- Reiterate UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Q2:12 Financial Update - Awaiting September PDUFA - Reiterate UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of July 8
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 1
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of May 27
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
LIFE SCIENCES-The Week Ahead in Life Sciences - Upcoming Events for the Week of May 6
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Q1:12 Cash Burn Higher Than Expected, We Continue to View Large Financing as Inevitable
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of April 29
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L